News related to Imitrex (Sumatriptan) and/or conditions it is approved for
Zogenix Announces Clinical Study Results For Sumatriptan DosePro™, A Novel Migraine Treatment
Source: Headache / Migraine News From Medical News Today [2008.06.30]
Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that it will present successful results from two clinical studies of sumatriptan DosePro, a product in development for treatment of acute migraine and cluster headache, at the 50th Annual American Headache Society Meeting in Boston, Massachusetts.
Data On Highly Effective Migraine Treatment Presented By OptiNose
Source: Headache / Migraine News From Medical News Today [2008.06.30]
OptiNose has announced that it presented important new data demonstrating the superior performance of its novel nasal drug delivery device with sumatriptan for the treatment of migraines. The Phase II results indicate that the drug-device combination achieves migraine relief as quickly and efficiently as injections without the discomfort, inconvenience and risk of needle-stick injuries. OptiNose presented the data at the Annual Scientific Meeting of the American Headache Society in Boston.
|
